How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
A Phase III, Prospective, Open-Label, Single-Arm, Multi-center Clinical Study to Assess the Diagnostic Performance and Safety of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer
Description:
In this study, 18F-Florastamin PET/CT will be performed in patients with suspected recurrence of prostate cancer, to assess the diagnostic performance and safety of 18F-Florastamin PET/CT imaging.
Sponsor:
HTA Co., Ltd.Contacts:
Wei Fanfanwei@sysucc.org.cn
+86 13602883007
Government Study Link:
NCT06754085 - Click here to see study onClinicalTrials.gov
18F-Florastamin
Isotope(s):
Target(s):
- PSMA
